COMZURY Trademark

Trademark Overview


On Wednesday, September 6, 2023, a trademark application was filed for COMZURY with the United States Patent and Trademark Office. The USPTO has given the COMZURY trademark a serial number of 98166836. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, September 13, 2024. This trademark is owned by Deciphera Pharmaceuticals, LLC. The COMZURY trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma

medical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma

pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and clinical trials
comzury

General Information


Serial Number98166836
Word MarkCOMZURY
Filing DateWednesday, September 6, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateFriday, September 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2024

Trademark Statements


Goods and Servicespharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
Goods and Servicesmedical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
Goods and Servicespharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and clinical trials

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 28, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 28, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 28, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDeciphera Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWaltham, MA 02451

Party NameDeciphera Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWaltham, MA 02451

Trademark Events


Event DateEvent Description
Friday, January 12, 2024ASSIGNED TO EXAMINER
Saturday, January 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 9, 2023NEW APPLICATION ENTERED
Thursday, September 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 20, 2024PUBLISHED FOR OPPOSITION
Thursday, February 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, February 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 16, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, September 13, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 13, 2024SOU EXTENSION 1 GRANTED
Friday, September 13, 2024SOU EXTENSION 1 FILED